“…Second, hyperglycemia is associated with delayed gastric emptying (15,37,53), and, hence, increased blood glucose levels might cause gastric dysmotility in IBD patients receiving corticosteroid therapy. Third, autonomic neuropathy (10,16,54) and alterations of intramural neurons (9,28,40,45) have been observed in IBD and might disturb gastrointestinal motility. Finally, there is evidence that release of several gastrointestinal neurohormonal mediators that regulate gastric functions may be altered in IBD (1,7,49,58,59); however, these results were conflicting, and roles of key regulators, particularly CCK, peptide YY (PYY), and glucagon-like peptide-1 (GLP-1) (51) have remained unclear.…”